Showing results (101-110 of 347) with videos related to

Sort By:
Pageof 35
Advances in Urology|May 9, 2012
Surgical Repair of Late Complications in Patients Having Undergone Primary Hypospadias Repair during Childhood: A New PerspectiveGuido Barbagli, Salvatore Sansalone, Rados Djinovic, et al.
Arab Journal of Urology|May 29, 2015
The spectrum of pelvic fracture urethral injuries and posterior urethroplasty in an Italian high-volume centre, from 1980 to 2013Guido Barbagli, Salvatore Sansalone, Giuseppe Romano, et al.
Urologia Internationalis|February 14, 2004
Intravesical vanilloids and neurogenic incontinence: ten years experienceMassimo Lazzeri, Michele Spinelli, Alberto Zanollo, et al.
Current Opinion in Urology|July 25, 2012
Bulbar urethroplasty: transecting vs. nontransecting techniquesGuido Barbagli, Salvatore Sansalone, Giuseppe Romano, et al.
BJU International|March 5, 2014
Clinical performance of serum isoform [-2]proPSA (p2PSA), and its derivatives %p2PSA and the Prostate Health Index, in men aged <60 years: results from a multicentric European studyNicola Fossati, Massimo Lazzeri, Alexander Haese, et al.
Sensors (Basel, Switzerland)|October 19, 2016
Application and Uses of Electronic Noses for Clinical Diagnosis on Urine Samples: A ReviewLaura Capelli, Gianluigi Taverna, Alessia Bellini, et al.
International Urology and Nephrology|October 7, 2015
Open partial nephrectomy: ancient art or currently available technique?Mauro Seveso, Fabio Grizzi, Giorgio Bozzini, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|May 31, 2019
Predictive factors for progression of patients with carcinoma in situ of the bladder at long-term follow-up: pure versus non-pure CISRodolfo Hurle, Massimo Lazzeri, Alberto Saita, et al.
European Urology|February 5, 2013
Serum isoform [-2]proPSA derivatives significantly improve prediction of prostate cancer at initial biopsy in a total PSA range of 2-10 ng/ml: a multicentric European studyMassimo Lazzeri, Alexander Haese, Alexandre de la Taille, et al.
The Journal of Urology|August 30, 2017
Active Surveillance for Low Risk Nonmuscle Invasive Bladder Cancer: A Confirmatory and Resource Consumption Study from the BIAS ProjectRodolfo Hurle, Massimo Lazzeri, Elena Vanni, et al.
Pageof 35